Prostate Cancer Trial, Recruiting NCT06534918 Sponsor: University of Miami Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06534918
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • Adults aged 18 or older, of any sex or gender
  • People who are able to give their own consent to participate
  • People who can read and understand English or Spanish
  • People who have been diagnosed with breast, prostate, or colorectal cancer, have finished their main cancer treatment at least 6 months ago, and show no signs of the cancer still being present
  • People whose treating cancer doctor has given written approval for them to take part
  • People who do not currently meet at least one of the American Cancer Society's healthy lifestyle guidelines — meaning they are either getting less than 150 minutes of moderate-to-vigorous physical activity per week, or not eating the recommended daily amounts of fruit and vegetables
  • People who have access to the internet through a smartphone, tablet, or computer
  • People who are willing to be randomly assigned to any group in the study

For healthcare providers (staff at the trial site):

  • People who provide full- or part-time care in an oncology (cancer care) setting at Sylvester Comprehensive Cancer Center
  • People who regularly use the electronic medical record system for patient documentation
  • People who are willing to take part in a 30–60 minute interview

Who may not be able to join:

  • People under 18 years of age
  • People who are unable to give their own consent
  • People who cannot read or understand English or Spanish
  • People whose doctor has determined that changing their diet or exercising would not be safe for them
  • People who are already getting more than 150 minutes of moderate-to-vigorous physical activity per week on average
  • People who are already meeting the American Cancer Society's full diet recommendations (enough vegetables, fruit, and whole grains, while limiting red meat, processed meats, sugary drinks, and highly processed foods)
  • People who have a history of dementia or a major psychiatric condition that could interfere with taking part in the study
  • People who have had a stroke, heart attack, or heart failure within the past year
  • People whose physical functioning is significantly limited due to their cancer (confirm with trial site regarding how this is assessed)
  • People with severe lymphedema (serious swelling, usually in the arms or legs), as determined by their doctor
  • People who are currently receiving physical therapy treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tracy Crane, PhD, RDN, University of Miami

Phone: 305-243-9832

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 September 2024
Est. completion
30 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of Survivors Who Agree to Participate; Percentage of Interventions Sessions Completed; Percentage of Participants Satisfied with the Intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov